Alberto Villanueva Selected Research

Mitochondrial Diseases (Mitochondrial Disease)

1/2022

Insights into cisplatin-induced neurotoxicity and mitochondrial dysfunction in Caenorhabditis elegans.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Alberto Villanueva Research Topics

Disease

87	Neoplasms (Cancer) 03/2024 - 03/2002
14	Colorectal Neoplasms (Colorectal Cancer) 11/2023 - 04/2006
10	Neoplasm Metastasis (Metastasis) 10/2020 - 06/2007
8	Breast Neoplasms (Breast Cancer) 01/2023 - 09/2009
7	Ovarian Neoplasms (Ovarian Cancer) 01/2018 - 10/2012
6	Carcinoma (Carcinomatosis) 01/2021 - 03/2009
5	Neurofibrosarcoma (MPNST) 10/2023 - 01/2013
5	Lung Neoplasms (Lung Cancer) 01/2021 - 12/2007
5	Carcinogenesis 01/2019 - 04/2009
5	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 01/2018 - 05/2009
3	Colonic Neoplasms (Colon Cancer) 03/2024 - 01/2018
3	Uveal melanoma 02/2024 - 10/2020
3	Melanoma (Melanoma, Malignant) 10/2023 - 07/2015
3	Adenocarcinoma of Lung 01/2020 - 01/2016
3	Ovarian Epithelial Carcinoma 01/2018 - 10/2012
3	Pulmonary Embolism 03/2013 - 05/2009
2	Liver Neoplasms (Liver Cancer) 12/2023 - 11/2009
2	Neuroblastoma 10/2023 - 10/2021
2	Endometrial Neoplasms (Endometrial Cancer) 11/2022 - 03/2017
2	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 04/2021 - 09/2015
2	Glioblastoma (Glioblastoma Multiforme) 09/2017 - 09/2012
2	Hepatocellular Carcinoma (Hepatoma) 03/2017 - 02/2016
2	Sarcoma (Soft Tissue Sarcoma) 03/2016 - 01/2016
2	Choriocarcinoma 08/2013 - 05/2009
2	Microsatellite Instability 10/2010 - 03/2009
1	Rhabdomyosarcoma 04/2022
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2022
1	Fibrosis (Cirrhosis) 12/2021
1	Cysts 12/2021
1	Liver Cirrhosis (Hepatic Cirrhosis) 12/2021
1	Cholangiocarcinoma 12/2021
1	Malignant Mesothelioma 11/2021
1	Weight Loss (Weight Reduction) 01/2021

Drug/Important Bio-Agent (IBA)

10	Cisplatin (Platino)FDA LinkGeneric 01/2022 - 05/2009
9	Biomarkers (Surrogate Marker)IBA 02/2024 - 11/2012
9	MicroRNAs (MicroRNA)IBA 01/2019 - 09/2008
8	RNA (Ribonucleic Acid)IBA 12/2023 - 03/2017
8	EnzymesIBA 12/2023 - 02/2016
8	Proteins (Proteins, Gene)FDA Link 12/2023 - 03/2002
8	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 10/2012
7	Messenger RNA (mRNA)IBA 12/2023 - 03/2002
6	Phosphotransferases (Kinase)IBA 11/2023 - 10/2012
4	PlatinumIBA 11/2021 - 10/2012
4	Sorafenib (BAY 43-9006)FDA Link 01/2020 - 05/2015
3	Drug CombinationsIBA 03/2024 - 01/2016
3	MethyltransferasesIBA 12/2023 - 06/2018
3	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 04/2022 - 07/2015
3	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022 - 05/2015
3	Oxaliplatin (Eloxatin)FDA LinkGeneric 05/2021 - 09/2016
3	Conditioned Culture MediaIBA 05/2021 - 10/2011
3	Therapeutic UsesIBA 01/2020 - 01/2017
3	Protein Isoforms (Isoforms)IBA 11/2019 - 10/2012
3	Fluorouracil (Carac)FDA LinkGeneric 01/2019 - 04/2006
2	quininibIBA 02/2024 - 01/2022
2	leukotriene D4 receptor (cysteinyl leukotriene receptor)IBA 02/2024 - 10/2020
2	5-Methylcytosine (5 Methylcytosine)IBA 12/2023 - 12/2019
2	Carrier Proteins (Binding Protein)IBA 12/2023 - 11/2019
2	ChromatinIBA 10/2023 - 07/2012
2	palbociclibIBA 01/2023 - 01/2020
2	S63845IBA 04/2022 - 01/2020
2	trametinibIBA 04/2022 - 01/2020
2	Erlotinib Hydrochloride (CP 358,774)FDA Link 02/2022 - 05/2014
2	carfilzomibIBA 01/2022 - 01/2021
2	Transfer RNA (tRNA)IBA 04/2021 - 01/2020
2	Adenosine Triphosphate (ATP)IBA 01/2020 - 02/2016
2	ProteomeIBA 12/2019 - 04/2014
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2018 - 05/2009
2	Small Interfering RNA (siRNA)IBA 01/2018 - 04/2016
2	LigandsIBA 01/2018 - 04/2009
2	SurvivinIBA 09/2016 - 01/2014
2	A-Form DNA (A-DNA)IBA 10/2012 - 09/2008
2	trans-activation responsive RNA-binding proteinIBA 03/2011 - 03/2009
1	Protein Phosphatase 2 (Protein Phosphatase 2A)IBA 03/2024
1	tyrosine receptor (receptor, tyrosine)IBA 10/2023
1	HLA Antigens (Human Leukocyte Antigens)IBA 01/2023
1	Cyclin IIBA 01/2023
1	Cyclin DIBA 01/2023
1	human ERBB2 proteinIBA 11/2022
1	Trastuzumab (Herceptin)FDA Link 11/2022
1	Paclitaxel (Taxol)FDA LinkGeneric 02/2022
1	adavosertibIBA 01/2022
1	PanobinostatIBA 01/2022
1	Bispecific AntibodiesIBA 01/2022
1	torinIBA 01/2022
1	8- (6- methoxypyridin- 3- yl)- 3- methyl- 1- (4- piperazin- 1- yl- 3- trifluoromethylphenyl)- 1,3- dihydroimidazo(4,5- c)quinolin- 2- oneIBA 01/2022
1	Mitogen-Activated Protein Kinase 8IBA 12/2021
1	Thioacetamide (Thioacetamid)IBA 12/2021
1	TunicamycinIBA 12/2021
1	Arsenic Trioxide (Trisenox)FDA Link 04/2021
1	Selenoproteins (Selenoprotein)IBA 04/2021
1	Lenalidomide (CC 5013)FDA Link 01/2021
1	Gefitinib (Iressa)FDA Link 01/2021
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2021
1	GSK-J4IBA 01/2021

Therapy/Procedure

26	Therapeutics 11/2022 - 08/2004
19	Drug Therapy (Chemotherapy) 01/2022 - 06/2007
5	Precision Medicine 10/2023 - 05/2015
4	Radiotherapy 01/2021 - 09/2009
3	Catheters 03/2013 - 05/2009
2	Immunotherapy 11/2021 - 09/2021